Francesco Bellomo
Papers
1
Total Citations
42
H-Index
1
About
Francesco Bellomo is a researcher dedicated to tackling one of medicine’s most challenging frontiers: rare diseases. His work centers on high-content drug screening, a powerful approach that uses automated imaging and analysis to test thousands of compounds on patient-derived cells. Bellomo’s major contribution lies in adapting this technique specifically for rare diseases, which are often neglected due to small patient populations and limited commercial incentives. His seminal 2017 paper, “High‐content drug screening for rare diseases,” has garnered 42 citations, serving as a foundational resource for researchers seeking to repurpose existing drugs or identify novel therapies for these conditions. By demonstrating that high-throughput methods can be effectively applied to rare disease models, Bellomo has helped bridge a critical gap between cutting-edge screening technology and the urgent need for treatments. His work underscores the collective burden of rare diseases and offers a practical, scalable path forward. For students and researchers, Bellomo exemplifies how innovative methodology can bring hope to underserved patient communities, proving that even the rarest conditions deserve a place in the drug discovery pipeline.
Research Focus
Key Achievements
Top Papers
- 1High‐content drug screening for rare diseases42 citations · 2017